Raymond James & Associates’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $363M | Buy |
586,785
+46,744
| +9% | +$28.9M | 0.22% | 81 |
|
|
2024
Q2 | $299M | Buy |
540,041
+26,475
| +5% | +$14.6M | 0.2% | 90 |
|
|
2024
Q1 | $298M | Buy |
513,566
+43,660
| +9% | +$25.4M | 0.2% | 86 |
|
|
2023
Q4 | $249M | Buy |
469,906
+3,962
| +0.9% | +$2.1M | 0.19% | 97 |
|
|
2023
Q3 | $236M | Buy |
465,944
+16,784
| +4% | +$8.5M | 0.2% | 91 |
|
|
2023
Q2 | $234M | Buy |
449,160
+10,399
| +2% | +$5.43M | 0.19% | 91 |
|
|
2023
Q1 | $253M | Buy |
438,761
+11,499
| +3% | +$6.63M | 0.22% | 85 |
|
|
2022
Q4 | $235M | Buy |
427,262
+26,674
| +7% | +$14.7M | 0.22% | 87 |
|
|
2022
Q3 | $203M | Buy |
400,588
+8,070
| +2% | +$4.09M | 0.21% | 97 |
|
|
2022
Q2 | $213M | Sell |
392,518
-6,628
| -2% | -$3.6M | 0.21% | 92 |
|
|
2022
Q1 | $236M | Buy |
399,146
+40,503
| +11% | +$23.9M | 0.2% | 95 |
|
|
2021
Q4 | $239M | Buy |
358,643
+8,456
| +2% | +$5.64M | 0.19% | 93 |
|
|
2021
Q3 | $200M | Buy |
350,187
+12,462
| +4% | +$7.12M | 0.18% | 100 |
|
|
2021
Q2 | $170M | Sell |
337,725
-2,957
| -0.9% | -$1.49M | 0.16% | 123 |
|
|
2021
Q1 | $155M | Sell |
340,682
-25,207
| -7% | -$11.5M | 0.16% | 125 |
|
|
2020
Q4 | $170M | Buy |
365,889
+19,377
| +6% | +$9.03M | 0.19% | 100 |
|
|
2020
Q3 | $153M | Buy |
346,512
+12,542
| +4% | +$5.54M | 0.19% | 90 |
|
|
2020
Q2 | $121M | Buy |
333,970
+12,205
| +4% | +$4.42M | 0.16% | 114 |
|
|
2020
Q1 | $91.3M | Buy |
321,765
+7,571
| +2% | +$2.15M | 0.14% | 121 |
|
|
2019
Q4 | $102M | Sell |
314,194
-3,962
| -1% | -$1.29M | 0.13% | 140 |
|
|
2019
Q3 | $92.7M | Sell |
318,156
-243
| -0.1% | -$70.8K | 0.13% | 144 |
|
|
2019
Q2 | $93.5M | Buy |
318,399
+19,436
| +7% | +$5.71M | 0.13% | 134 |
|
|
2019
Q1 | $81.8M | Buy |
298,963
+21,994
| +8% | +$6.02M | 0.12% | 152 |
|
|
2018
Q4 | $62M | Buy |
276,969
+3,628
| +1% | +$812K | 0.11% | 174 |
|
|
2018
Q3 | $66.7M | Buy |
273,341
+26,382
| +11% | +$6.44M | 0.1% | 189 |
|
|
2018
Q2 | $51.2M | Buy |
246,959
+30,033
| +14% | +$6.22M | 0.09% | 219 |
|
|
2018
Q1 | $44.8M | Buy |
216,926
+17,427
| +9% | +$3.6M | 0.08% | 228 |
|
|
2017
Q4 | $37.9M | Buy |
199,499
+12,439
| +7% | +$2.36M | 0.07% | 262 |
|
|
2017
Q3 | $35.4M | Buy |
187,060
+12,925
| +7% | +$2.45M | 0.07% | 261 |
|
|
2017
Q2 | $30.4M | Sell |
174,135
-126
| -0.1% | -$22K | 0.07% | 282 |
|
|
2017
Q1 | $26.8M | Buy |
174,261
+43,311
| +33% | +$6.65M | 0.06% | 297 |
|
|
2016
Q4 | $18.5M | Buy |
130,950
+16,455
| +14% | +$2.32M | 0.05% | 399 |
|
|
2016
Q3 | $18.2M | Buy |
114,495
+19,537
| +21% | +$3.11M | 0.05% | 369 |
|
|
2016
Q2 | $14M | Buy |
94,958
+5,134
| +6% | +$759K | 0.04% | 425 |
|
|
2016
Q1 | $12.7M | Buy |
89,824
+7,857
| +10% | +$1.11M | 0.04% | 439 |
|
|
2015
Q4 | $11.6M | Buy |
81,967
+5,132
| +7% | +$728K | 0.04% | 473 |
|
|
2015
Q3 | $9.4M | Buy |
76,835
+12,282
| +19% | +$1.5M | 0.04% | 505 |
|
|
2015
Q2 | $8.38M | Buy |
64,553
+4,298
| +7% | +$558K | 0.03% | 584 |
|
|
2015
Q1 | $8.1M | Buy |
60,255
+4,580
| +8% | +$615K | 0.04% | 533 |
|
|
2014
Q4 | $6.98M | Buy |
55,675
+9,711
| +21% | +$1.22M | 0.03% | 537 |
|
|
2014
Q3 | $5.59M | Buy |
45,964
+1,359
| +3% | +$165K | 0.03% | 577 |
|
|
2014
Q2 | $5.26M | Buy |
44,605
+13,187
| +42% | +$1.56M | 0.03% | 611 |
|
|
2014
Q1 | $3.78M | Buy |
31,418
+5,300
| +20% | +$637K | 0.03% | 695 |
|
|
2013
Q4 | $2.91M | Buy |
26,118
+5,118
| +24% | +$570K | 0.02% | 766 |
|
|
2013
Q3 | $1.94M | Sell |
21,000
-34,534
| -62% | -$3.18M | 0.02% | 901 |
|
|
2013
Q2 | $4.7M | Buy |
+55,534
| New | +$4.7M | 0.04% | 453 |
|